Litigation (Drug Pricing Matters) (Details)	Sep. 30, 2023	Sep. 30, 2023 state	May 18, 2023 statement	Jun. 26, 2020 statement
Loss Contingencies [Line Items]
Number Of Challenged Statements				46
Number Of Challenged Statements Dismissed			45
Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]
Loss Contingencies [Line Items]
Number of states	34
Multi District Litigation [Member]
Loss Contingencies [Line Items]
Number of states	44	44
Anticompetitive Conduct with Generic Drugs [Member]
Loss Contingencies [Line Items]
Number of states	45
Amended Anticompetitive Conduct with Generic Drugs [Member]
Loss Contingencies [Line Items]
Number of states	40